2020
Depression, anxiety, and patterns of mental health care among men with prostate cancer on androgen deprivation therapy (ADT).
Tsao P, Ross R, Bohnert A, Mukherjee B, Caram M. Depression, anxiety, and patterns of mental health care among men with prostate cancer on androgen deprivation therapy (ADT). Journal Of Clinical Oncology 2020, 38: 12100-12100. DOI: 10.1200/jco.2020.38.15_suppl.12100.Peer-Reviewed Original ResearchDiagnosis of depressionMental health carePatterns of mental health careAndrogen deprivation therapyReuptake inhibitorsHealth careProstate cancerSerotonin-norepinephrine reuptake inhibitorsReceipt of psychotherapySerotonin reuptake inhibitorsNorepinephrine reuptake inhibitorsDevelopment of depressionIncreased risk of depressionRisk of depressionRisk of dependenceDatabase of commercially insured patientsCare of menPsychiatric medicationsPsychotherapyAnxietyCognitive impairmentDepressionCommercially insured patientsIncident useAnalytic cohort
2019
Patient and Provider Variables Associated with Variation in the Systemic Treatment of Advanced Prostate Cancer.
Caram M, Wang S, Tsao P, Griggs J, Miller D, Hollenbeck B, Lin P, Mukherjee B. Patient and Provider Variables Associated with Variation in the Systemic Treatment of Advanced Prostate Cancer. Urology Practice 2019, 6: 234-242. PMID: 31276025, PMCID: PMC6605774, DOI: 10.1097/upj.0000000000000020.Peer-Reviewed Original ResearchMetastatic castration-resistant prostate cancerAndrogen signaling inhibitorsAdvanced prostate cancerFirst-line treatmentProstate cancerSystemic treatment of advanced prostate cancerDatabase of commercially insured patientsTreatment of advanced prostate cancerCastration-resistant prostate cancerSignaling inhibitorsPre-existing heart failureImproved overall survivalTreatment of menCommercially insured patientsSipuleucel-TRadium-223Overall survivalSystemic treatmentTreatment patternsNovel therapiesMedical oncologistsHeart failureMultivariate analysisProvider specialtyDocetaxelFactors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate Cancer
Caram M, Ross R, Lin P, Mukherjee B. Factors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate Cancer. JAMA Network Open 2019, 2: e192589. PMID: 31002323, PMCID: PMC6481456, DOI: 10.1001/jamanetworkopen.2019.2589.Peer-Reviewed Original ResearchConceptsMinimally symptomatic metastatic castration-resistant prostate cancerSipuleucel-TProstate cancerSymptomatic metastatic castration-resistant prostate cancerDatabase of commercially insured patientsMetastatic castration-resistant prostate cancerCastration-resistant prostate cancerAge of patientsRetrospective cohort studyFactors associated with useAssociated with patientsCommercially insured patientsPatterns of treatmentConcurrent therapyTreated patientsCohort studyMultivariate analysisCancer therapyTherapyPatientsPhysician factorsCancerBarriers to treatmentBinomial logistic regressionLogistic regression